dalteparin has been researched along with Acute Necrotizing Pancreatitis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zemskov, VS | 1 |
| Kriuchina, EA | 1 |
| Koval'skaia, IA | 1 |
1 trial available for dalteparin and Acute Necrotizing Pancreatitis
| Article | Year |
|---|---|
[The influence of clexane on the fibronectin content in the blood plasma in patients with destructive pancreatitis].
Topics: Adult; Aged; Anticoagulants; Enoxaparin; Female; Fibronectins; Humans; Male; Middle Aged; Pancreatit | 2001 |